Companies /Healthcare
Syndax Pharmaceuticals Inc
NASDAQ: SNDX Biotechnology
$16.85
▼ $0.05 (−0.30%) today
Markets open · 11:20am ET

Syndax Pharmaceuticals (SNDX) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
67%
EPS beat rate
−0.01%
Avg. EPS surprise
Consecutive EPS misses
SNDX vs Market · 30-day return after each reportSNDXS&P 500
0%+30%+60%−17.8%+5.2%Q1 25+56.0%+2.8%Q2 25+32.4%+1.6%Q3 25+8.8%−8.3%Q4 25−4.0%+4.7%Q1 26+3.2%+0.1%Q2 26
0%+30%+60%Q1 25Q3 25Q1 26
SNDX EPS Trend · estimate vs actualEstimateActual
$-1.20$-0.80$-0.40$0.00$-1.27$-0.98Q1 25$-1.01$-0.83Q2 25$-0.71$-0.70Q3 25$-0.58$-0.78Q4 25$-0.59$-0.48Q1 26$-0.44$-0.55Q2 26
$-1.20$-0.80$-0.40$0.00Q1 25Q3 25Q1 26
SNDX Revenue Trend · estimate vs actualEstimateActual
$0$30.0M$60.0M$16.2M$20.0MQ1 25$26.6M$38.0MQ2 25$48.0M$45.9MQ3 25$64.7M$68.7MQ4 25$69.8M$64.9MQ1 26$79.3M$72.8MQ2 26
$0$30.0M$60.0MQ1 25Q3 25Q1 26

How Often Does Syndax Pharmaceuticals Beat Earnings Estimates?

Syndax Pharmaceuticals beat EPS estimates in 4 of its last 6 reported quarters.

SNDX quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-0.55 est. $-0.44 −26.00% $72.8M est. $79.3M −8.24%
Q1 2026 $-0.48 est. $-0.59 +18.75% $64.9M est. $69.8M −7.11%
Q4 2025 $-0.78 est. $-0.58 −34.88% $68.7M est. $64.7M +6.15%
Q3 2025 $-0.70 est. $-0.71 +1.55% $45.9M est. $48.0M −4.38%
Q2 2025 $-0.83 est. $-1.01 +17.50% $38.0M est. $26.6M +42.48%
Q1 2025 $-0.98 est. $-1.27 +23.04% $20.0M est. $16.2M +23.87%

Figures from SEC filings and company reports. Not investment advice.